Larvol Delta - Study-to-Evaluate-the-Safety-and-Efficacy-of-ATYR1923-In-Patients-With-Severe-Pneumonia-Related-to-COVID19

Stalaris (ATYR1923) - aTyr Pharma, Kyorin

http://clinicaltrials.gov/ct2/show/NCT04412668

Jan 29, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next